Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 12/1999

01-12-1999 | Short communication

Gastric emptying in Type II (non-insulin-dependent) diabetes mellitus before and after therapy readjustment: no influence of actual blood glucose concentration

Authors: A. Holzäpfel, A. Festa, G. Stacher-Janotta, H. Bergmann, N. Shnawa, W. Brannath, G. Schernthaner, G. Stacher

Published in: Diabetologia | Issue 12/1999

Login to get access
Metadata
Title
Gastric emptying in Type II (non-insulin-dependent) diabetes mellitus before and after therapy readjustment: no influence of actual blood glucose concentration
Authors
A. Holzäpfel
A. Festa
G. Stacher-Janotta
H. Bergmann
N. Shnawa
W. Brannath
G. Schernthaner
G. Stacher
Publication date
01-12-1999
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 12/1999
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s001250051311

Other articles of this Issue 12/1999

Diabetologia 12/1999 Go to the issue

Letters

Islet autoantibodies in cord blood could be a risk factor for future diabetes

Short communication

An untranslated insertion variant in the uncoupling protein 2 gene is not related to body mass index and changes in body weight during a 26-year follow-up in Danish Caucasian men

OriginalPaper

List of referees

OriginalPaper

Erratum: Diabetologia (1999) 42: 1050–1054

Letters

Is islet autoimmunity really detectable at birth?

Letters

Expression of kinase-inactive mutant insulin receptors does not rescue insulin receptor-deficient mice from perinatal death
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits